Epstein Se

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Exercise Studies in Tetralogy of Fallot: A Review

Effects of Diltiazem on Left Ventricular Systolic and Diastolic Function in Hypertrophic Cardiomyopathy**This study was supported in part by Grant 18/1/57 1994–1995 from the Italian Ministry of University and Scientific Research (MURST 60%), Rome, Italy.

Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy

Perioperative Management of Antithrombotic Therapy

Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future

Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study

Ventricular arrhythmias in postoperative tetralogy of Fallot

Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

Hypertrophic Cardiomyopathy

Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases

Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

Treatment of infective endocarditis: a 10-year comparative analysis.

Nonsurgical Septal Reduction for Hypertrophic Obstructive Cardiomyopathy

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Aspergillus terreus infective endocarditis on a porcine heterograft valve

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

Mechanoelectrical Interaction in Tetralogy of Fallot

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Influence of surgery on the natural history of rheumatic mitral and aortic valve disease

Sudden Cardiac Death

Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy

Ventricular arrhythmia in unrepaired and repaired tetralogy of Fallot. Relation to age, timing of repair, and haemodynamic status.

Living with prosthetic heart valves

Right Ventricular Function in Cardiovascular Disease, Part I

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies

Beta blockade during and after myocardial infarction: An overview of the randomized trials

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

The clinical importance of cardioselectivity and lipophilicity in beta blockers

Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults

Tachycardias of Right Ventricular Origin

The frontiers of cardiomyopathy.

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Mitral Valve Replacement

Atrioventricular valve replacement with the Hancock porcine xenograft: a five year clinical experience.

Current status of the Starr-Edwards cloth-covered prosthetic cardiac valves.

Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.

Long-term hemodynamic and electrocardiographic assessment following operative repair of tetralogy of Fallot.

Medical and surgical therapy of hypertrophic cardiomyopathy.

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.